The European Association of Nuclear Medicine (EANM) has launched a survey on the use of dosimetry in radionuclide therapy. The group is also seeking new members for its neuroimaging and technologist committees.
The survey, launched by the EANM's internal dosimetry task force, aims to determine the range of radiation dose used in radionuclide therapy procedures in Europe, according to the association. The survey consists of a one-page form for each therapy procedure and takes about five minutes to complete, the EANM said. The survey will close on 31 July.
In other EANM news, the association is calling for new members for its technologist and neuroimaging committees. Applications are due by 22 July for the technologist committee and by 22 September for the neuroimaging committee.
